Olema Pharmaceuticals (OLMA) Amortizatization of Intangibles (2021 - 2026)
Olema Pharmaceuticals (OLMA) posted quarterly Amortizatization of Intangibles of $869000.0 for Q1 2023, up 14583.33% year-over-year from N/an in Q1 2022, and up 52.19% quarter-over-quarter from $571000.0 in Q4 2022.
Powered by 
Analysis
Olema Pharmaceuticals (OLMA) Amortizatization of Intangibles (2021 - 2026) Analysis & Trends
Olema Pharmaceuticals (OLMA) has reported Amortizatization of Intangibles for 3 consecutive years, with $869000.0 the latest figure, recorded in Q1 2023.
- In Q1 2023, Amortizatization of Intangibles rose 14583.33% year-over-year to $869000.0; the TTM figure through Mar 2023 stood at $1.7 million (up 862.39% YoY), while the FY2025 annual figure was -$6.3 million, up 23.03% from the prior year.
- Amortizatization of Intangibles climbed to $869000.0 in Q1 2023 per OLMA's latest filing, from $571000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $869000.0 in Q1 2023 and bottomed at -$82000.0 in Q3 2021.
- Historically, Amortizatization of Intangibles has averaged $153333.3 across 3 years, with a median of -$6000.0 in 2022.
- Annual changes were most pronounced in 2022 — Amortizatization of Intangibles jumped 90.62% — and 2023, when it surged 14583.33%.
- Olema Pharmaceuticals' Amortizatization of Intangibles stood at -$56000.0 in 2021, then jumped by 1119.64% to $571000.0 in 2022, then jumped by 52.19% to $869000.0 in 2023.
- Business Quant data shows OLMA's Amortizatization of Intangibles at $869000.0 in Q1 2023, $571000.0 in Q4 2022, and $190000.0 in Q3 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.33 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 678,000.00 |
| 10 | Olema Pharmaceuticals | 1.13 Bn | 1.13 Bn | - | 300,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 300,000.00 |
| Mar 31, 2026 | 301,000.00 |
| Dec 31, 2025 | -7.17 Mn |
| Sep 30, 2025 | 300,000.00 |
| Jun 30, 2025 | 288,000.00 |
| Mar 31, 2025 | 287,000.00 |
| Dec 31, 2024 | -9.04 Mn |
| Sep 30, 2024 | 288,000.00 |
| Jun 30, 2024 | 287,000.00 |
| Mar 31, 2024 | 288,000.00 |
| Dec 31, 2023 | 324,000.00 |
| Sep 30, 2023 | 320,000.00 |
| Jun 30, 2023 | 326,000.00 |
| Mar 31, 2023 | 327,000.00 |
| Dec 31, 2022 | 326,000.00 |
| Sep 30, 2022 | 327,000.00 |
| Jun 30, 2022 | 325,000.00 |
| Mar 31, 2022 | 323,000.00 |
| Dec 31, 2021 | 1.44 Mn |
| Sep 30, 2021 | -82,000.00 |